CDH1 and colorectal carcinoma: These data point towards a potential important role of E-cadherin in response to Cetuximab in CRC cell lines, since strong or weak membranous expression is associated with responding or non-responding CRC cell lines and since down-regulation of E-cadherin in responding DLD1 cells abrogates response to Cetuximab.